Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Watch: In a heated debate in Washington, key players spar over drug pricing policies

By Ike Swetlitz Nov. 30, 2018

Reprints
STAT Plus November 29 Panel event
Panelists speak at a STAT Plus event on drug pricing politics in Washington, D.C. STAT

WASHINGTON — Sparks flew between a patient advocate and a drug industry representative. The middlemen and the manufacturers reached a strained detente. Statistics were offered and disputed, as were policy options both controversial and staid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ike Swetlitz

Washington Correspondent

Ike is a Washington correspondent, reporting at the intersection of life science and national politics.

Tags

Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
New weight loss drugs are changing the narrative on…
New weight loss drugs are changing the narrative on obesity, with a push from pharma
Flawed herpes testing leads to many false positives —…
Flawed herpes testing leads to many false positives — and needless suffering
Novartis data set up multibillion-dollar battle over breast cancer…
Novartis data set up multibillion-dollar battle over breast cancer drugs
Ohio attorney general accuses pharmacy benefit managers of drug…
Ohio attorney general accuses pharmacy benefit managers of drug price fixing
Bernie Sanders’ accidentally great drug pricing idea
Bernie Sanders’ accidentally great drug pricing idea

Recommended Stories